Target intelligence / Profile preview

Beta-site APP-cleaving enzyme 1 (BACE1)

Target: BACE1
Molecular classification: Enzyme, Aspartic protease, Type I transmembrane protein

Overview

Beta-site APP-cleaving enzyme 1 (BACE1) is an aspartic protease that initiates the cleavage of amyloid precursor protein (APP) at the β-secretase site, leading to the production of amyloid-beta peptides (Aβ). This step is rate-limiting for Aβ production and is a key event implicated in Alzheimer's disease pathogenesis, making BACE1 a major drug target for AD therapy development. BACE1 also plays a role in myelin sheath formation.

Other names: β-secretase 1Memapsin-2Aspartyl protease 2 (ASP2)Membrane-associated aspartic protease 2

Mechanism of action

Inhibition of amyloid-beta peptide production through blockade of BACE1 enzymatic activity.

Biological functions

Amyloid precursor protein cleavageAmyloid-beta peptide productionMyelin sheath formation

Disease associations

Alzheimer's disease

Safety considerations

Potential for off-target effects due to BACE1's role in other biological processes (e.g., myelination).Challenges in achieving sufficient brain penetration with BACE1 inhibitors.

Beyond the preview

Go deeper on Beta-site APP-cleaving enzyme 1 (BACE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-site APP-cleaving enzyme 1 (BACE1).

Explore the full profile